Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis

OBJECTIVE: It has been hypothesised that the use of ACE inhibitors and angiotensin receptor blockers (ARBs) might either increase or reduce the risk of severe or lethal COVID-19. The findings from the available observational studies varied, and summary estimates are urgently needed to elucidate whet...

Descripción completa

Detalles Bibliográficos
Autores principales: Flacco, Maria Elena, Acuti Martellucci, Cecilia, Bravi, Francesca, Parruti, Giustino, Cappadona, Rosaria, Mascitelli, Alfonso, Manfredini, Roberto, Mantovani, Lorenzo G, Manzoli, Lamberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Cardiac Risk Factors and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371482/
https://www.ncbi.nlm.nih.gov/pubmed/32611676
http://dx.doi.org/10.1136/heartjnl-2020-317336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371482/
https://www.ncbi.nlm.nih.gov/pubmed/32611676
http://dx.doi.org/10.1136/heartjnl-2020-317336

Ejemplares similares